Status:

COMPLETED

Novel Biomarkers for Risk Prediction of Contrast-Induced Acute Kidney Injury Post Coronary Angiography

Lead Sponsor:

Sapere Bio

Collaborating Sponsors:

University of North Carolina, Chapel Hill

Conditions:

Acute Kidney Injury

Renal Insufficiency

Eligibility:

All Genders

18+ years

Brief Summary

Contrast-induced acute kidney injury (CI-AKI) has been recognized as the third most common cause of hospital acquired AKI, after hypotension-associated hypo-perfusion and post-operative AKI. The devel...

Eligibility Criteria

Inclusion

  • Adult patients (\>18 yo) undergoing invasive coronary angiography with or without percutaneous coronary intervention (PCI), that are predicted to have ≥14% risk of developing AKI as defined by Mehran et al.
  • Medically compliant and able to consent and follow detailed directions
  • Agree to additional collection of blood sample 48-72h post cardiac catheterization

Exclusion

  • Presence of acute, active infection (e.g. HIV, pneumonia, septic shock).
  • Contrast media exposure within last 48h
  • Presenting with systolic time-segment elevation myocardial infarction.
  • Presence of cardiogenic shock
  • Presence of hemodynamic instability or requiring pressors or intra-aortic balloon pump
  • Severe kidney disease with estimated glomerular filtration rate \<30 mL/min/1.73m2 or receiving dialysis for end stage renal disease
  • Kidney transplant and liver transplant patients and all patients currently on immunosuppressants
  • Severe heart failure with known ejection fraction \<25%
  • Prior heart transplant
  • Chronic liver disease /cirrhosis
  • Patients actively undergoing chemotherapy or radiation treatment for any indication.

Key Trial Info

Start Date :

January 1 2015

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2016

Estimated Enrollment :

185 Patients enrolled

Trial Details

Trial ID

NCT02263820

Start Date

January 1 2015

End Date

December 1 2016

Last Update

August 17 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UNC Center for Heart & Vascular Care

Chapel Hill, North Carolina, United States, 27599